Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.

Chow, CK; Ramasundarahettige, C; Hu, W; AlHabib, KF; Avezum, AJr; Cheng, X; Chifamba, J; Dagenais, G; Dans, A; Egbujie, BA; +31 more... Gupta, R; Iqbal, R; Ismail, N; Keskinler, MV; Khatib, R; Kruger, L; Kumar, R; Lanas, F; Lear, S; Lopez-Jaramillo, P; McKee, M; Mohammadifard, N; Mohan, V; Mony, P; Orlandini, A; Rosengren, A; Vijayakumar, K; Wei, L; Yeates, K; Yusoff, K; Yusuf, R; Yusufali, A; Zatonska, K; Zhou, Y; Islam, S; Corsi, D; Rangarajan, S; Teo, K; Gerstein, HC; Yusuf, S; PURE investigators; (2018) Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study. The lancet Diabetes & endocrinology. ISSN 2213-8587 DOI: https://doi.org/10.1016/S2213-8587(18)30233-X

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S2213-8587(18)30233-X

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar